Monte Rosa Therapeutics, Inc. (GLUE) Operating cash flow 2020–2025
Monte Rosa Therapeutics, Inc. (GLUE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.8MFY2025 · since FY2020: -$23.1M → -$22.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.8M | -154.3% |
| FY2024 | $42.0M | +195.9% |
| FY2023 | -$43.8M | +52.6% |
| FY2022 | -$92.5M | -55.8% |
| FY2021 | -$59.4M | -157.5% |
| FY2020 | -$23.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice